Cyclo Therapeutics, Inc. (CYTH)

Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
INDUSTRIAL ORGANIC CHEMICALS
CEO:
N. Scott Fine
Employees:
5
6714 NW 16TH STREET, SUITE B, GAINSVILLE, FL 32653
386-418-8060

Cyclo Therapeutics, Inc. (previously CTD Holdings, Inc.) was organized as a Florida corporation on August 9, 1990, with operations beginning in July 1992. In conjunction with a restructuring in 2000, we changed our name from Cyclodextrin Technologies Development, Inc., or CTDI, to CTD Holdings, Inc.; CTDI was then incorporated as a Florida corporation and became a wholly owned subsidiary of CTD Holdings, Inc. We are a clinical stage biotechnology company focused on the use of cyclodextrins in drug development. The Company has launched clinical trial programs, initially in Europe and the US, for its Trappsol® Cyclo™ as treatment for Neiman-Pick Type C disease (NPC). We also sell cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs with continuing growth in research and new product development

Data derived from most recent annual or quarterly report
Market Cap 12.781 Million Shares Outstanding6.455 Million Avg 30-day Volume 26.04 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.94
Price to Revenue19.7707 Debt to Equity0.0097 EBITDA-14.27 Million
Price to Book Value2.0005 Operating Margin-901.1512 Enterprise Value14.891 Million
Current Ratio5.074 EPS Growth0.6 Quick Ratio4.477
1 Yr BETA 0.8503 52-week High/Low 13.0 / 1.88 Profit Margin-900.9365
Operating Cash Flow Growth-75.7023 Altman Z-Score0.0452 Free Cash Flow to Firm -11.449 Million
Earnings Report2022-08-11
View SEC Filings from CYTH instead.

View recent insider trading info

Funds Holding CYTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYTH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

15 Thousand total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TATE JEFFREY CHIEF OPERATING OFFICER

  • Officer
  • Director
32,160 2022-05-16 4

SIEGER MARKUS

  • Director
85,912 2022-05-03 5

OSTRONIC FRANCIS PATRICK

  • Director
133,525 2022-05-03 18

TOIG RANDALL M.

  • Director
48,532 2022-05-03 3

FINE N SCOTT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
74,907 2022-02-28 8

FINE JOSHUA M CHIEF FINANCIAL OFFICER

  • Officer
31,141 2022-02-28 2

LISJAK MICHAEL ERIC CHIEF REGULATORY OFFICER

  • Officer
31,141 2022-02-28 2

KJEMS LISE LUND CHIEF MEDICAL OFFICER

  • Officer
31,141 2022-02-28 3

HRYNKOW SHARON HEMOND CHIEF SCIENTIFIC OFFICER

  • Officer
19,350 2021-12-02 2

STRATTAN CE RICK

  • Director
6,700 2021-08-27 1

SHANAHAN WILLIAM S

  • Director
6,700 2021-08-27 1

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • 10% Owner
No longer subject to file 2020-09-29 0

NOVIT, L.P.

NOVIT U.S., INC.

KUSMIERZ KATARZYNA

  • 10% Owner
31,517,582 2020-08-27 0

FARNAN JOSEPH J JR

  • Director
1,350,000 2018-12-31 0

FAILS GEORGE L

  • Director
1,685,221 2017-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TATE JEFFREY - Director - Officer CHIEF OPERATING OFFICER

2022-05-16 13:01:28 -0400 2022-05-16 P 3,000 $2.12 a 32,160 direct 1.4218 1.4218 2 0.0 1

OSTRONIC FRANCIS PATRICK - Director

2022-05-04 21:27:50 -0400 2022-05-03 A 5,249 a 133,525 direct 0.8658 -6.9264 0.8658 2 -11.6883 5

SIEGER MARKUS - Director

2022-05-04 21:27:48 -0400 2022-05-03 A 4,223 a 85,912 direct 0.8658 -6.9264 0.8658 2 -11.6883 5

TOIG RANDALL M. - Director

2022-05-04 21:26:26 -0400 2022-05-03 A 2,267 a 48,532 direct 0.8658 -6.9264 0.8658 2 -11.6883 5

OSTRONIC FRANCIS PATRICK - Director

2022-05-04 21:28:24 -0400 2022-05-03 A 5,249 a 133,525 direct 0.8658 -6.9264 0.8658 2 -11.6883 5

TATE JEFFREY - Director - Officer CHIEF OPERATING OFFICER

2022-04-29 15:36:26 -0400 2022-04-29 P 300 $2.70 a 28,095 direct -2.6718 -17.5573 0.0 1 -17.5573 6

TATE JEFFREY - Director - Officer CHIEF OPERATING OFFICER

2022-04-29 15:36:26 -0400 2022-04-29 P 1,065 $2.71 a 29,160 direct -2.6718 -17.5573 0.0 1 -17.5573 6

TATE JEFFREY - Director - Officer CHIEF OPERATING OFFICER

2022-04-29 15:36:26 -0400 2022-04-28 P 635 $2.50 a 27,795 direct -2.6718 -17.5573 0.0 1 -17.5573 6

OSTRONIC FRANCIS PATRICK - Director

2022-04-07 10:00:29 -0400 2022-04-06 A 5,000 $2.90 a 128,276 direct 1.5101 -7.3826 -33.557 3.0201 11 -33.557 31

SIEGER MARKUS - Director

2022-03-30 10:28:07 -0400 2022-03-29 P 10,000 $2.73 a 81,689 direct 8.5616 0.0 -26.3699 9.9315 4 -30.137 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYCLO THERAPEUTICS INC CYTH 2022-05-20 22:15:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 21:45:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 21:15:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 20:45:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 20:15:05 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 19:45:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 19:15:04 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 18:45:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 18:15:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 17:45:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 17:15:03 UTC -47.415 48.235 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 16:45:04 UTC -47.8904 48.7104 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 16:15:03 UTC -47.8904 48.7104 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 15:45:03 UTC -47.8904 48.7104 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 15:15:03 UTC -47.8904 48.7104 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 14:45:03 UTC -47.8904 48.7104 300000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 14:15:04 UTC -47.8904 48.7104 250000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 13:45:03 UTC -47.8904 48.7104 250000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 13:15:03 UTC -47.8904 48.7104 250000
CYCLO THERAPEUTICS INC CYTH 2022-05-20 12:45:03 UTC -47.8904 48.7104 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments